InvestorsHub Logo
Followers 829
Posts 119591
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 6607

Monday, 06/27/2022 3:58:10 PM

Monday, June 27, 2022 3:58:10 PM

Post# of 6724
ABUS’ AB-836 HBV capsid inhibitor shows_safety_signal_in_phase-1b_trial—see slide #18 from today’s EASL CC:

https://investor.arbutusbio.com/static-files/a51bd38d-cd8a-4001-8077-6d0c842359b9:

As a result of the safety signal, ABUS will rerun a phase-1a trial (i.e. retest healthy volunteers) to gain further insight on the relevance of the signal.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News